CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 57 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,221 | -62.4% | 33,928 | -34.1% | 0.00% | – |
| Q2 2023 | $61,771 | +970.9% | 51,476 | +944.1% | 0.00% | – |
| Q1 2023 | $5,768 | +48.5% | 4,930 | +0.3% | 0.00% | – |
| Q4 2022 | $3,884 | -35.3% | 4,916 | +0.5% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 4,893 | -0.1% | 0.00% | – |
| Q2 2022 | $5,000 | -90.6% | 4,900 | -83.5% | 0.00% | – |
| Q1 2022 | $53,000 | -48.5% | 29,722 | -55.7% | 0.00% | – |
| Q4 2021 | $103,000 | -92.2% | 67,158 | -89.6% | 0.00% | – |
| Q3 2021 | $1,317,000 | +8680.0% | 648,600 | +14192.6% | 0.00% | – |
| Q2 2021 | $15,000 | +200.0% | 4,538 | +66.9% | 0.00% | – |
| Q1 2021 | $5,000 | +150.0% | 2,719 | +20.1% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 2,264 | +0.7% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 2,248 | +6.2% | 0.00% | – |
| Q2 2020 | $2,000 | -81.8% | 2,116 | -88.6% | 0.00% | – |
| Q1 2020 | $11,000 | +450.0% | 18,586 | +829.3% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |